HLTC02H3 Lecture 12: Lecture 12.docx

54 views8 pages

skyhyena673

2 Apr 2012

School

Department

Course

Professor

For unlimited access to Class Notes, a Class+ subscription is required.

Document Summary

Lecture 12: women"s health issues hiv/aids and breast cancer. Vulnerability: gender differences: fear of certain groups (haiti, asia) if they become in contact with these people, they become infected, visibility has to do with social stratification (class, sexual orientation), gender neutral. Research carried with male samples and assumed everything is the same for women: research and treatment on aids began in 1980s. Hard for women to have access to drugs to prolong lives. Women are vulnerable because of this since it is seen as gay men s disease. There is an image of women seen as helpless victims. Aids and identity politics gay male disease. Pathologizing concepts of deviance : helps us understand relationship between hiv and gender and also look at social economic importance, global inequality. Women of rich and poor countries were affected. Women in poor countries didn t have access to treatment, which could have been helpful: many meetings occurred around issues of identity.

Related Questions

We live in a highly gender differentiated society. Boys and girls start receiving differential treatment from the world almost as soon as they are born. Throughout childhood, they are exposed to images of males and females that are highly stereotypical (e.g., Bob is the builder and Wendy is his assistant). As your textbook indicates, children very quickly become knowledgeable about gender stereotypes and their stereotypes are adult-like by 11 years of age. And, the cycle repeats itself with each succeeding generation.

Scholars in many different disciplines have long discussed the social inequality and personal disappointments gender stereotypes help create. The dos and don't s for men and women have long been the topic of academic debates, political rallies, and self-help books. Given these circumstances, it appears that living in a gender neutral world would be a step in the right direction; perhaps many social problems can be eliminated if this were to happen.

Given such a possibility, would you be willing to raise your children in a gender neutral manner? Could you? Pros? Cons? There is a lot to consider...

Cite at least one reference

Ch. 12 Case Study: A Patient Offered New Cancer Treatment Harriet Abeline had faced bad news before. She was diagnosed with breast cancer five years ago and underwent a lumpectomy and radiation treatment. Two years later, a routine mammogram revealed another lump. She used similar treatment for this tumor. Harriet understood medicine. For years she had worked as a recruiter for a major drug company interviewing and hiring scientists and physicians. The company was a reputable and honest business and developed drugs that were used all over the world. With each recurrence of cancer, she researched her situation and the available drugs being used for treatment. She also discovered that some cases of breast cancer are caused by a genetic predisposition. With each google search, she read about the experimental treatments that were available for end-stage breast cancer, keeping them in the back of her mind. Her doctor told her that the cancer had spread to her bones. Harriet was frightened. Dr. Hill understood her fear. Harriet had been working with cancer patients for years and had recently been using some of the newer treatments available for late-stage cancers. 1. What should Harriet do? Should she be tested to see if she carries mutant alleles BRCA1 and BRCA2? 2. If Dr. Hill told Harriet that no other treatment could help her, might that make a difference in her decision to participate in the trial? Why or why not? 3. Many trials need end-stage patients to see how a drug might affect individuals who are very sick or dying. Can these patients really understand what the trials are about and give consent? 4. What should Dr. Hill tell Harriet about the proposed treatment before she agrees? List 5 items. 5. Is there anything that a researcher or physician shouldnât tell a patient? 6. One serious problem in clinical trials is that researchers often cannot persuade patients to participate. Why do you think that is?

Ch. 12 Case Study: A Patient Offered New Cancer Treatment

Harriet Abeline had faced bad news before. She was diagnosed with breast cancer five years ago and underwent a lumpectomy and radiation treatment. Two years later, a routine mammogram revealed another lump. She used similar treatment for this tumor.

Harriet understood medicine. For years she had worked as a recruiter for a major drug company interviewing and hiring scientists and physicians. The company was a reputable and honest business and developed drugs that were used all over the world.

With each recurrence of cancer, she researched her situation and the available drugs being used for treatment. She also discovered that some cases of breast cancer are caused by a genetic predisposition. With each google search, she read about the experimental treatments that were available for end-stage breast cancer, keeping them in the back of her mind.

Her doctor told her that the cancer had spread to her bones. Harriet was frightened. Dr. Hill understood her fear. Harriet had been working with cancer patients for years and had recently been using some of the newer treatments available for late-stage cancers.

1. What should Harriet do? Should she be tested to see if she carries mutant alleles BRCA1 and BRCA2?

2. If Dr. Hill told Harriet that no other treatment could help her, might that make a difference in her decision to participate in the trial? Why or why not?

3. Many trials need end-stage patients to see how a drug might affect individuals who are very sick or dying. Can these patients really understand what the trials are about and give consent?

4. What should Dr. Hill tell Harriet about the proposed treatment before she agrees? List 5 items.

5. Is there anything that a researcher or physician shouldnât tell a patient?

6. One serious problem in clinical trials is that researchers often cannot persuade patients to participate. Why do you think that is?

HLTC02H3 Lecture 12: Lecture 12.docx

Document Summary

Get access

Related Documents

HLTC02H3 Lecture Notes - Breast Cancer, Identity Politics, Heterosexuality

SOC 0471 Chapter Notes - Chapter 10: Gay Bar, Homophobia, United States Department Of Justice

[SOCL 1260] - Final Exam Guide - Everything you need to know! (50 pages long)

Related Questions